A prior investigation revealed that the expression of the SIRT3 protein was markedly reduced in ovarian cancer tissues and in the highly metastatic HO-8910PM cell line (Dong et al., 2016; Shi et al., 2020). This evidence concerns the gene SIRT3 and ovarian carcinoma.